CTEVClaritev Corporation
Price
-56%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality strong, a flag to check, growth steady, the market undecided.
Charts
As reported to the SEC, without any scoring.
Claritev Corporation (CTEV) reported revenue of $257M in Q2 2026 (quarter ended Jun 30, 2026), up 6.6% from the same quarter a year earlier. That came with a gross margin of 74% and net loss of $59M. For the full year FY2025, revenue was $965M (+3.7% year on year) and net income −$284M. The next results filing is expected around Nov 6, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 15, 2026Election of Director On September 14, 2026, the Board of Directors (the "Board") of Claritev Corporation (the "Company") appointed Mr. Ben Letham to the Board as a Class I director to fill the vacancy created by Mr. John Prince's passing, and appointed Mr. Letham to the Risk Committee of the Board, in each case …Director or officer change · Form 8-K
- Jul 6, 2026Other Information On July 6, 2026, Claritev Corporation (“Claritev”) was notified of the death of Mr. John Prince. Mr. Prince served as a respected member of the Claritev Board of Directors since June 2023 and served on the Audit Committee at the time of his death.Other event · Form 8-K
- Apr 30, 2026On April 29, 2026, the stockholders of Claritev Corporation (the “Company”) approved an amendment (the “Amendment”) to the Claritev Corporation 2020 Omnibus Incentive Plan, as amended (the “2020 Plan”), at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Health Information Services
Ranks #12 of 20 by RyuScore